On June 11, when the world watches the opening ceremony of the Soccer World Cup at the ultra-modern Soccer City Stadium in Johannesburg, it will also have its eyes on LANXESS. The colored components in the striking stadium facade of glass-fiber-reinforced concrete panels are based on iron oxide pigments from LANXESS, a global specialty Chemicals [...]
German specialty chemicals company LANXESS India Private Limited is participating at Paint India 2010 which is held in Mumbai from March 4-6 at the Bombay Exhibition Centre. PAINT INDIA, established in 1993, is the premier coatings exposition for the coatings industry in the Indian sub-continent. This exhibition helps foster the interaction between manufacturers and distributors [...]
Banking life saving umbilical cord blood of your child will offer a potential resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. Since 1988, stem cells have been effective in treating more than 80 life-threatening diseases including different types of Cancers, Thalassemia, Blood and Metabolic disorders, Immunodeficiency Ailments and [...]
Hong Kong’s pharmaceutical market is the thirteenth largest in Asia Pacific, behind Malaysia and ahead of Bangladesh. Combined sales of prescription products and over-the-counter (OTC) medicines reached US$939mn in 2008, an 8.4% increase compared to the previous year. Drug spending accounts for 0.42% of GDP, and annual per capita expenditure is US$134. Through to 2013, [...]
Q3 FY2010 – Revenue up by 6% to Rs. 961 crore – EBITDA up 52% to Rs. 238 crore – PAT up 215% at Rs. 101 crore 9M FY2010 Revenue at Rs. 2,791 crore, EBITDA at Rs. 599 crore and PAT at Rs. 284 crore Sharpening Business Focus In line with the continued strategy of [...]
Cord Blood America Inc. (OTC:CBAI) may not be your average business model for a medical stock, but growth in stem cell research and the company’s ambitious expansion plans make it worth a second look! Cord Blood America Inc. (CBAI) collects, tests, processes and preserves umbilical cord blood for use in future stem cell therapy. As [...]
ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has completed the previously announced sale of shares of its Series E convertible preferred stock pursuant to a registered direct offering to institutional investors, representing gross proceeds to ADVENTRX of approximately $19 million. ADVENTRX plans to use the net proceeds from the offering to fund [...]
Shares of ADVENTRX (AMEX:ANX) began to bounce off session lows amid news that the company has become the subject of takeover rumors. Even though ADVENTRX is an early stage oncology company it counts Carl Icahn’s Ichan Capital Management, Renaissance Technologies, UBS AG, the Bank of New York Mellon and Barclay’s Global Investors among its top [...]
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that senior management will present at the OneMedForum 2010 Finance Conference on January 13, 2010 at 2:00 p.m. PST. The conference will be held at the Sir Francis Drake Hotel in San Francisco. A live audio webcast of the company’s presentation will be available at the Investors section [...]
A top Senate Democrat for the first time Tuesday acknowledged that the party is prepared to deal with health care reform by using a controversial legislative tactic known as the “nuclear option.” A top Senate Democrat for the first time Tuesday acknowledged that the party is prepared to deal with health care reform by using [...]